Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania ; volume:19 ; number:1 ; day:7 ; month:2 ; year:2019 ; pages:1-6 ; date:12.2019
BMC infectious diseases ; 19, Heft 1 (7.2.2019), 1-6, 12.2019
- Urheber
-
Juma, Saumu Pazia
Maro, Athanasia
Pholwat, Suporn
Mpagama, Stellah G.
Gratz, Jean
Liyoyo, Alphonse
Houpt, Eric R.
Kibiki, Gibson S.
Mmbaga, Blandina T.
Heysell, Scott K.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-019-3757-1
- URN
-
urn:nbn:de:101:1-2019031301005425318405
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Juma, Saumu Pazia
- Maro, Athanasia
- Pholwat, Suporn
- Mpagama, Stellah G.
- Gratz, Jean
- Liyoyo, Alphonse
- Houpt, Eric R.
- Kibiki, Gibson S.
- Mmbaga, Blandina T.
- Heysell, Scott K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
How to mathematically optimize drug regimens using optimal control
Unsuspected and extensive transmission of a drug-susceptible Mycobacterium tuberculosisstrain
Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting
Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis
Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis
Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens
Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens
Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru
Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States
Drugs : evaluations of drugs and drug therapy
Evolution of extensively drug-resistant Mycobacterium tuberculosisfrom a susceptible ancestor in a single patient
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
How to mathematically optimize drug regimens using optimal control
Unsuspected and extensive transmission of a drug-susceptible Mycobacterium tuberculosisstrain
Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting
Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis
Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis
Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens
Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens
Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru
Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States
Drugs : evaluations of drugs and drug therapy
Evolution of extensively drug-resistant Mycobacterium tuberculosisfrom a susceptible ancestor in a single patient
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
How to mathematically optimize drug regimens using optimal control
Unsuspected and extensive transmission of a drug-susceptible Mycobacterium tuberculosisstrain
Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting
Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis
Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis
Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens
Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens
Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru
Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States
Drugs : evaluations of drugs and drug therapy